Similar Stocks · Benchmarked Analysis · Peer Group

Peer Group Analysis

Configuration
Company Price d* Change d* Volume, Avg. k, d* Market Cap. d* Revenue Profit Net Earnings Free Cash Flow Dividend Yield P/E EPS Gross Margin % Net Margin % ROE % ROA % Quick Ratio % Shares Outstanding d*
Biotechnology Average - - - - - - 13,594.86 882.88 226.07 -68.10 38.34 0.00 6.4005 -0.46 -1.2795 -26.9889 -0.10 -0.11 7.9982 - -
Maximum - - - - - - 465,034.00 65,349.00 25,407.00 99,050.00 5,305.00 0.01 701.8537 6.70 3.0051 85.3485 0.15 8.35 61.5621 - -
Minimum - - - - - - 0.00 0.00 -1,175.00 -56,335.00 -1,185.00 0.00 -164.8536 -8.99 -101.7758 -1,444.7800 -1.56 -12.64 0.0007 - -
Blueprint Medicines Corporation BPMC 96.62 -3.25 -3.25% 430 vs. 609 6,137.00 96.00 89.00 -102.00 -2,250.00 1.4500 16.6530 0.0000 0.9168 0.9274 0.2869 0.0858 3.4266 63.00
United Therapeutics Corporation UTHR 400.87 0.43 0.11% 343 vs. 398 17,896.00 677.00 306.00 338.00 6,333.00 6.5200 8.7477 0.0000 0.8924 0.4524 0.0574 0.0472 3.5035 44.00
Incyte Corporation INCY 80.58 -0.95 -1.17% 1,690 vs. 1,876 15,523.00 880.00 169.00 209.00 329.00 0.7600 18.7480 0.0000 0.9308 0.1925 0.0314 0.0238 3.2913 192.00
Alnylam Pharmaceuticals, Inc. ALNY 268.95 -10.87 -3.88% 1,006 vs. 817 34,689.00 494.00 -65.00 -94.00 -7,075.00 -0.5200 -73.3326 0.0000 0.8665 -0.1334 0.3007 -0.0172 2.8593 128.00
Apellis Pharmaceuticals, Inc. APLS 29.26 -0.32 -1.08% 1,166 vs. 2,415 3,639.00 172.00 -66.00 -133.00 -2,903.00 -0.5400 -27.6326 0.0000 0.8802 -0.3855 -0.2491 -0.0798 2.7985 124.00
Seagen Inc. SGEN 228.74 -0.16 -0.07% 19,392 vs. 1,634 43,154.00 648.00 -215.00 -79.00 -2,756.00 -1.1500 -46.2406 0.0000 0.7452 -0.3327 -0.0846 -0.0594 1.9572 188.00
Madrigal Pharmaceuticals, Inc. MDGL 339.04 -0.62 -0.18% 367 vs. 347 7,394.00 0.00 -147.00 -149.00 -1,483.00 -7.3800 -8.6674 0.0000 0.0000 0.0000 -0.1734 -0.1363 9.2623 21.00
Karuna Therapeutics, Inc. KRTX 329.83 0.09 0.03% 1,283 vs. 971 12,599.00 0.00 -113.00 -111.00 -997.00 -3.0100 -26.2644 0.0000 0.0000 0.0000 -0.0908 -0.0852 18.6075 38.00
Krystal Biotech, Inc. KRYS 187.22 -8.65 -4.42% 248 vs. 215 5,384.00 45.00 0.00 14.00 -268.00 0.0300 1336.3467 0.0000 0.9465 0.0206 0.0012 0.0011 12.2870 28.00
Reata Pharmaceuticals, Inc. RETA 172.36 0.04 0.02% 1,909 vs. 954 6,566.00 22.00 192.00 -70.00 -1,490.00 5.1200 5.4820 0.0000 0.9628 8.4849 2.2110 0.3840 2.8209 38.00
BioMarin Pharmaceutical Inc. BMRN 66.13 -0.24 -0.36% 1,091 vs. 1,755 12,603.00 648.00 88.00 12.00 -532.00 0.4700 46.3847 0.0000 0.7850 0.1366 0.0175 0.0129 1.5477 190.00
Ultragenyx Pharmaceutical Inc. RARE 47.84 -2.89 -5.70% 856 vs. 704 4,417.00 108.00 -170.00 -203.00 -3,558.00 -2.0300 -5.7986 0.0000 0.7576 -1.5683 -1.2169 -0.1306 2.1127 92.00
IVERIC bio, Inc. ISEE 39.95 0.15 0.38% 10,801 vs. 4,945 5,512.00 0.00 -70.00 -50.00 -937.00 -0.5200 -11.8078 0.0000 0.0000 0.0000 -0.1480 -0.1151 15.2365 137.00
Halozyme Therapeutics, Inc. HALO 59.61 -1.48 -2.42% 1,464 vs. 1,383 7,584.00 195.00 76.00 125.00 167.00 0.6100 17.0691 0.0000 0.7647 0.3922 0.4321 0.0417 5.0088 127.00
Exelixis, Inc. EXEL 35.85 -0.34 -0.94% 1,618 vs. 2,039 10,238.00 425.00 37.00 50.00 -258.00 0.1200 47.8131 0.0000 0.9500 0.0878 0.0175 0.0133 3.2273 285.00
*d means the data is delayed 15 minutes at minimum.
More Due Diligence
Compare Fundamentals
Leverage our visualization and data tables to compare over 25 years of financial data for AAPL and its peers.
Watchlist
Keep an eye one one or all of the stocks by building a new watchlist.
Intrinsic Values
Utilize our versatile Gordan Growth Model for ALNY and its peers to uncover potential buy and sell opportunities.